SCIENTURE HOLDINGS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
SCIENTURE HOLDINGS, INC. (SCNX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 8.14 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-28
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 8.17M shares, a 0.78% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 8.16M shares, a 1.25% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.12M shares, a 7.14% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 8.10M shares.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 8.14M shares, a 5.59% increase from fiscal 2020.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 7.71M shares, a 29.96% increase from fiscal 2019.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 5.93M shares.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 34.09M shares, a 8.06% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 8.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 8.17M shares derived: average of 2 quarters · filed 2022-03-28 | 8.15M shares derived: average of 3 quarters · filed 2022-03-28 | 8.14M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 8.16M shares 10-Q · filed 2021-10-25 | 8.14M shares derived: average of 2 quarters · filed 2021-10-25 | 8.13M shares 10-Q · filed 2021-10-25 | |
| 2021-06-30 | 8.12M shares 10-Q · filed 2021-07-26 | 8.11M shares 10-Q · filed 2021-07-26 | ||
| 2020-12-31 | 8.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 8.08M shares derived: average of 2 quarters · filed 2022-03-28 | 7.92M shares derived: average of 3 quarters · filed 2022-03-28 | 7.71M shares 10-K · filed 2022-03-28 |
| 2020-09-30 | 8.06M shares 10-Q · filed 2021-10-25 | 7.82M shares derived: average of 2 quarters · filed 2021-10-25 | 7.57M shares 10-Q · filed 2021-10-25 | |
| 2020-06-30 | 7.58M shares 10-Q · filed 2021-07-26 | 7.32M shares 10-Q · filed 2021-07-26 | ||
| 2019-12-31 | 5.93M shares 10-K · filed 2021-03-29 | |||
| 2018-09-30 | 34.74M shares 10-Q · filed 2018-10-26 | 34.61M shares derived: average of 2 quarters · filed 2018-10-26 | 34.73M shares 10-Q · filed 2018-10-26 | 34.35M shares derived: average of 4 quarters · filed 2018-10-26 |
| 2018-06-30 | 34.48M shares 10-Q · filed 2018-07-27 | 34.47M shares 10-Q · filed 2018-07-27 | 34.22M shares derived: average of 3 quarters · filed 2018-07-27 | 34.18M shares derived: average of 4 quarters · filed 2018-07-27 |
| 2018-03-31 | 34.06M shares 10-Q · filed 2018-04-27 | 34.09M shares derived: average of 2 quarters · filed 2018-04-27 | 34.09M shares derived: average of 3 quarters · filed 2018-04-27 | 33.56M shares derived: average of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | 34.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | 34.10M shares derived: average of 2 quarters · filed 2018-03-02 | 33.39M shares derived: average of 3 quarters · filed 2018-03-02 | 34.09M shares 10-K · filed 2018-03-02 |
| 2017-09-30 | 34.08M shares 10-Q · filed 2017-11-07 | 33.03M shares derived: average of 2 quarters · filed 2017-11-07 | 34.08M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 31.99M shares 10-Q · filed 2017-08-04 | 34.06M shares 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | 34.26M shares 10-Q · filed 2018-04-27 | |||
| 2016-12-31 | 31.54M shares 10-K · filed 2018-03-02 | |||
| 2015-12-31 | 31.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 31.36M shares derived: average of 2 quarters · filed 2017-03-30 | 31.32M shares 10-K · filed 2017-03-30 | |
| 2015-09-30 | 31.27M shares 10-Q · filed 2015-11-02 | 31.27M shares 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |